Nouscom (private company)

See something wrong or missing? Let us know
Offices:Basel
Business model:B2B

Nouscom is a Swiss biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.

Investors: we tracked 11 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 79.15M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Nouscom

Name Criteria
France AbolerIS Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Acesion Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Synklino
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Cardior Pharmaceuticals
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 6
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom PetMedix
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden Asgard Therapeutics
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top